A new antitumor antibiotic, carminomycin (NSC-180024).
D000617:Aminoglycosides / Q000008:administration & dosage / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use; D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000008:administration & dosage / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use*; D055598:Chemical Phenomena; D002621:Chemistry; D003630:Daunorubicin / Q000627:therapeutic use; D006410:Hematopoiesis / Q000187:drug effects; D007275:Injections, Intravenous; D007700:Kinetics; D007928:Lethal Dose 50; D007939:Leukemia L1210 / Q000188:drug therapy; D051379:Mice; D009279:Naphthacenes / Q000008:administration & dosage / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use*; D013997:Time Factors
D000617:Aminoglycosides; D000903:Antibiotics, Antineoplastic; D009279:Naphthacenes; D003630:Daunorubicin